Anlotinib Combined with Sintilimab As First-Line Treatment in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma (nccrr): Preliminary Results from an Exploratory Prospective Multicentre Clinical Study.
Journal of Clinical Oncology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要